← Sanara MedTech Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $5.5m $6.3m $5.8m $11.8m $15.6m $24.1m $45.8m $65.0m $86.7m $103.1m
Cost of Goods and Services Sold $944k $806k $507k $1.2m $1.6m $2.3m $6.4m $7.9m $8.1m $7.5m
Gross Profit $4.6m $5.5m $5.3m $10.6m $14.0m $21.8m $39.5m $57.1m $78.5m $95.6m
Operating Expenses $4.8m $5.4m $5.8m $13.3m $19.0m $29.2m $51.7m $61.4m $85.2m $88.3m
Operating Income (Loss) ($272k) $120k ($502k) ($2.7m) ($5.0m) ($7.4m) ($12.2m) ($4.2m) ($6.7m) $7.3m
Additional Financial Items
Amortization of Intangible Assets — — — $90k $224k $376k $2.0m $3.2m $3.9m $2.5m
Income (Loss) from Continuing Operations before Income Taxes, Domestic — — — $2.8m $4.4m — ($13.9m) ($4.4m) $1.9m ($393k)
Income (Loss) from Continuing Operations, Per Basic Share — — — ($2.8m) ($4.4m) — — — ($1.9m) ($0)
Income (Loss) from Continuing Operations, Per Diluted Share — — — ($2.8m) ($4.4m) — — — ($1.9m) ($0)
Income (Loss) from Equity Method Investments — — ($10k) — — ($617k) ($380k) — ($90k) ($952k)
Interest Income, Other — — — — — — — — $22k $4k
Other Income — — — $10k $15k — — — — —
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest — — — $2.8m $4.4m — ($13.9m) ($4.4m) $1.9m ($393k)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent — — — ($2.8m) ($4.4m) — — — $1.9m ($393k)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent — — — — — — — — $8.0m ($37.2m)
Net Income (Loss) Attributable to Parent ($416k) $331k ($601k) ($2.8m) ($4.4m) ($8.0m) ($7.9m) ($4.3m) ($9.7m) ($37.6m)
Net Income (Loss) Available to Common Stockholders, Basic ($677k) $192k ($732k) — — ($7.9m) — — — —
Net Income (Loss) Attributable to Noncontrolling Interest — — — ($22k) ($89k) ($72k) ($155k) ($137k) ($247k) ($5k)
Earnings Per Share, Basic ($0.01) $0.00 $0.00 ($1.32) ($0.76) ($1.08) ($1.00) ($0.52) ($1.14) ($4.36)
Earnings Per Share, Diluted ($0.01) $0.00 $0.00 ($1.32) ($0.76) ($1.08) ($1.00) ($0.52) ($1.14) ($4.36)
Weighted Average Number of Shares Outstanding, Basic 108.6m 111.4m 217.2m 2.1m 5.7m 7.3m 7.9m 8.3m 8.5m 8.6m
Weighted Average Number of Shares Outstanding, Diluted 108.6m 208.6m 217.2m 2.1m 5.7m 7.3m 7.9m 8.3m 8.5m 8.6m
Research and Development Expense — — — — $40k $559k $3.4m $4.1m $5.7m $5.1m
General and Administrative Expense $3.9m $5.3m $5.7m $13.1m $18.7m $28.1m $46.0m $57.0m $76.6m $16.7m
Selling, General and Administrative Expense $819k $0 $5.7m $13.1m $18.7m $28.1m $46.0m $57.0m $76.6m $78.7m
Other Nonoperating Income (Expense) ($144k) $211k ($99k) ($96k) $589k ($618k) ($1.7m) ($225k) ($3.2m) ($7.7m)
Business Combination, Acquisition Related Costs — — — — — — — — $1.4m —
Interest Expense $174k $127k $87k $106k $12k $711 $285k $476k $3.1m $6.8m
Interest Expense, Debt — — — $62k $8k — — — — —
Operating Lease, Expense — — — — — $202k $297k $434k $555k $549k
Other General and Administrative Expense $819k $0 — — — — — — — —
Selling and Marketing Expense — — — — — — — — — $62.0m
Income Tax Expense (Benefit) $0 $0 $0 $0 $0 — ($5.8m) — ($48k) —

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.